Regional Anesthetic Injection
ProcedureDraw of venous blood and application of paravertebral and erector spinae plane block
NCT Number: NCT07648810
The goal of this clinical trial is to find the difference in immune response between two types of regional anesthesia in female patients suffering from breast cancer.
The main question it aims to answer is there a difference in the immune response between paravertebral block and erector spinal plane block.
Hypothresis of the study is that paravertebral block with propofol induces less immune response in surgical treatment of breast cancer patients than erector spinal plane block.
Participants will be asked to sign the informant consent. They will be given either paravertebral block or erector spinae plane block with general anesthesia using propofol. Their venous blood will be taken 1 hour prior surgery and 24 and 48 hours after surgery.
Trial opening soon.
Get Notified18 year–70 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Draw of venous blood and application of paravertebral and erector spinae plane block
Draw of venous blood 24 hours after surgery
Time frame: From enrollment to 30 days post surgery
Contact information is provided by the study sponsor or research team.
Clinical Hospital Center Rijeka
Other
Immunologic Response in Breast Cancer Before and After Application of Paravertebral and Erector Spinae Plane Block
Acronym: IRPVBESP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07529496
Breast Cancer - Female
East Jerusalem, Palestinian Territories
View Trial DetailsNCT07482384
Breast Cancer, Breast Cancer - Female
Boston, Massachusetts, United States
View Trial DetailsNCT07103447
Breast Cancer - Female
View Trial DetailsNCT06952270
Behavior, Breast Cancer
Pontevedra, Spain
View Trial Details